pillbase.ru

Emgality

Active substance: galcanezumab

Galcanezumab

Centralised EU authorisationActive

Marketing holder: Eli Lilly Nederland B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • EMGALITY
    INJECTION, SOLUTION · GALCANEZUMAB 120 mg/mL
    0002-1436
    Eli Lilly and Company
  • EMGALITY
    INJECTION, SOLUTION · GALCANEZUMAB 120 mg/mL
    0002-2377
    Eli Lilly and Company
  • EMGALITY
    INJECTION, SOLUTION · GALCANEZUMAB 100 mg/mL
    0002-3115
    Eli Lilly and Company
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12091-69e3-7bc3-9d96-f06864ced9b6,01a12098-498f-725b-9f33-2b839b0778e8,01a1209b-0395-73c0-9e67-ac8c22199fbf;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004648
Registration status
Active
ATC code
N02
Sources
  • product · EMA · EMEA/H/C/004648 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004648 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004648 · Verified 2026-10-09